Flunixin Meglumine Injectable Solution (Im, Iv) Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (IM, IV)

Available Strengths: 100 mg/mL

Reference Brands: Banamine (US)

Category: Veterinary Product

Flunixin Meglumine Injectable solution (IM, IV) is available in Injectable solution (IM, IV) and strengths such as 100 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Flunixin Meglumine Injectable solution (IM, IV) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Flunixin Meglumine Injectable solution (IM, IV) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Flunixin Meglumine injection is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in line with GMP and IVDR standards. In the US, FDA approval involves comprehensive clinical data and safety evaluations, mainly for pain and inflammation in horses, livestock, and pigs. In the EU, CE marking certifies conformity with veterinary medicinal regulations. These products undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective flunixin meglumine formulations worldwide.